BioSpace News Archive

Neurocrine Biosciences announced on Monday that it has received approval from the U.S. Food and Drug Administration for its once-daily oral drug, Ongentys, as an add-on treatment to levodopa/carbidopa for the treatment of Parkinson’s disease.

Todos Medical Ltd. (OTCQB: TOMDF) , a commercial in vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, as well as point-of-care and lab-based tests for novel coronavirus (COVID-19 or COVID), today announced positive data for its Colloidal Gold point-of-care (POC) 2 to 10 minute fingerprick blood antibody test

In their brand new report " COVID-19 Diagnostics ", global market research firm IDTechEx benchmarked more than 100 commercial devices across various technologies, providing a deep insight into the technology trends and biotech innovations surrounding the COVID-19 global response. For more information on this report, please visit www.IDTech

The Canadian Pharmacists Association is pleased to announce that, through a financial contribution from Innovative Medicines Canada, it has secured and is distributing more than 200,000 surgical masks to community pharmacies across the country to support pharmacists and their teams who are continuing to deliver care to patients amid the COVID-19 pandemic.

Sonic Healthcare USA’s network of clinical laboratories has begun performing antibody testing for SARS-CoV-2 (COVID-19) to complement our existing molecular PCR testing.

EMTensor, a global leader in Electromagnetic Tomography (ET) imaging solutions, and QuantalRF, an innovator in breakthrough wireless RF technology, today announced that the companies have signed an agreement to jointly evaluate QuantalRF’s Quantal technology within EMTensor’s Generation 4 ET brain scanning device.

The shareholders in Biotage AB, Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the Annual General Meeting, to be held on Thursday, June 4, 2020, at 4.00 p.m., at Biotage AB’s head office, Vimpelgatan 5 in Uppsala, Sweden..

Sensiva Health is pleased to announce its substantial capacity for COVID-19 testing at this time and its anticipated ability to rapidly scale that capacity to help meet the volume of COVID-19 testing needed in the United States to allow for a safe social reopening.

Median Technologies (Paris:ALMDT) (ALMDT), The Imaging Phenomics Company®, provides an update on its performance for Q1 2020 and a review of its commitment to tackle Covid-19.

Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, together with Johns Hopkins University and Geisinger Health, today announced data from the landmark DETECT-A study